Safety and effectiveness of remdesivir in hospitalized patients with COVID-19 and severe renal impairment: experience at a large medical center.

Hsuan-Yu ChangChia-Chen HsuLi-Fang HuChian-Ying ChouYuh-Lih ChangChih-Chia LuLi-Jen Chang

Published in: Annals of medicine (2024)

Hospitalized COVID-19 patients receiving remdesivir with severe renal impairment had an increased risk of AKI, hospital mortality, and COVID-19 disease progression compared to patients without severe renal impairment.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
early onset
newly diagnosed
ejection fraction
chronic kidney disease
randomized controlled trial
systematic review
healthcare
peritoneal dialysis
prognostic factors
drug induced
patient reported outcomes
adverse drug
acute care